Pilot Study Based on Technology Solutions for Hypertension Care
Launched by ISTITUTO AUXOLOGICO ITALIANO · Apr 5, 2023
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
The study falls within the scope of the HSMonitor project, a pre-commercial tender for the development of telematics solutions aimed at optimising patient health status and disease management. Specifically, the aim of this study is to test whether the adoption of HSMonitor solutions by healthcare professionals and patients improves the management of patients with high blood pressure.
This will be a randomised controlled trial where patients with hypertension will be randomised either to one of the two digital solutions or to standard care.
The present pilot study is planned to be carried ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with essential hypertension (\>140/90 mmHg or normal BP with antihypertensive treatment)
- • Basic ICT knowledge and ability to access the internet at home and on mobile devices
- • aged 18+
- • ability to provide written informed consent, giving informed consent.
- • written informed consent
- Exclusion Criteria:
- • inability to consent
- • chronic renal replacement therapy (haemodialysis, peritoneal dialysis or transplantation) or if, at baseline, there is a history of active malignancy within the last five years
- • pregnancy
- • illiterate
- • younger than 18 years
- • being a prisoner
- • being institutionalized
- • the patient is mentally or psychiatrically ill
- • the patient has barriers to understand the implications of participation to the study
- • the patient is critically ill or dying
- • the patient is extremely poor
- • the patient has a learning disability
- • the patient is sedated or unconscious
- • the patient is a refugee with no permanent permission to stay
- • the patient does not have a good command of the language
- • the patient has problems in cognitive, juridical, and deferential dimensions
About Istituto Auxologico Italiano
Istituto Auxologico Italiano is a prominent Italian research institute dedicated to advancing medical science and improving patient care through innovative clinical research. With a strong focus on metabolic diseases, cardiovascular health, and neuropsychological disorders, the institute integrates clinical practice with cutting-edge research to foster the development of new therapeutic strategies. Committed to ethical standards and patient safety, Istituto Auxologico Italiano collaborates with various national and international partners, contributing significantly to the global medical community while ensuring high-quality care and support for its patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Trial Officials
Gianfranco Parati, MD
Principal Investigator
Istituto Auxologico Italiano
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported